CRCNS: PKMzeta-Dependent Protein Synthesis Maintains Synaptic Plasticity

CRCNS:PKMzeta 依赖性蛋白质合成维持突触可塑性

基本信息

项目摘要

DESCRIPTION (provided by applicant): We all have memories that date back to our youth; we remember the house we lived in at age 4; we remember a favorite schoolteacher. The mechanism for storing these memories is believed to be the long-term plasticity of synaptic connections within specific neuronal circuits. However, this putative cellular basis of memory relies on proteins that typically have lifetimes far shorter than the memory. Here exactly lies a fundamental problem of long-term memory and synaptic plasticity: How can memories be stored for a human lifetime on the basis of proteins that are continuously degrading? Recently, it was shown that the brain-specific PKC isoform, protein kinase M??(PKM?), plays a unique role in maintaining both late long-term potentiation (L-LTP) of synapses and long-term memory. This crucial observation, however, does not explain how PKM??can overcome the natural degrading effect of protein turnover and diffusion. The central hypothesis of this proposal is that PKM??, through its control of its own synthesis, can form a bi-stable system, which can account for the maintenance of synapse specific long-term plasticity and memory. Here we propose to mathematically formulate this hypothesis within a biophysical model, and to analyze this model so as to propose testable experimental predictions. We then will directly test these predictions on PKM?-mediated persistent synaptic potentiation, using novel techniques tailored for testing the theory. Intellectual Merit: The finding that PKM??is both necessary and sufficient for the maintenance of synaptic plasticity and long-term memory has fundamentally changed the field of learning and memory, but much needs to be learned about the mechanisms that can actually accomplish the persistence of long-term plasticity and memory. This proposal addresses these questions using a combined theoretical and experimental approach. Such a theory in which bi-stability depends on regulation of translation is novel not only for neuroscience but also for biology in general. Our collaboration is uniquely qualified to carry out the proposed work because the Shouval lab has ample experience in modeling synaptic plasticity in collaboration with experimental groups, and the Sacktor lab has pioneered the science of PKM??and has ample experience with the proposed techniques. The experimental techniques include two new methodologies necessary for testing the predictions. First, we propose to test the model's predictions on protein translation in L-LTP, not by general protein synthesis inhibitors that may have issues of toxicity and indirect effects, but by use of antisense oligodeoxynucleotides directed to the translation start site of PKM??mRNA to specifically block PKM??synthesis in induction and maintenance. Second, because PKM?-mediated potentiation is both highly stable and yet rapidly reversible, we will use a fast-flow hippocampal slice chamber optimized for the study of the maintenance of L-LTP to test key predictions of the model. The proposed stochastic simulations of translation-dependent bi-stability are also novel in computational biology. Broader Impact: As the first demonstrated molecular mechanism of experience-dependent, long-term information storage in the brain, PKM??has significant clinical implications, and within the last year has been shown to contribute to in the biology of a variety of neurological and psychiatric diseases, including post-traumatic stress disorder, central neuropathic pain, and drug abuse. In order to assist the rapidly growing interest in PKM??in many labs, we will make our model accessible to the larger community, allowing for other scientists to test, modify, and incorporate their findings into the model, thus accelerating the pace of scientific discovery. Because an important goal for NSF is to integrate research and education, we will train a diverse pool of students. Our labs already train undergraduates, the Shouval lab takes undergraduates each summer through an REU program (PI S. Cox, Rice), and a UT system grant (PI H. Shouval), and local undergraduates throughout the year, and the Sacktor lab has had a long history of mentoring local disadvantaged high school students (e.g., through the Intel program). Both labs are dedicated to public outreach; for example, an article on PKM??and memory was on the front page of The New York Times. We are eager to extend this type of outreach to the domain of the interaction between theory and experiment in biological sciences.
描述(由申请人提供):我们都有可以追溯到我们年轻时的记忆;我们记得我们4岁时住过的房子;我们记得一位最喜欢的老师。存储这些记忆的机制被认为是特定神经元回路内突触连接的长期可塑性。然而,这种假定的记忆细胞基础依赖于蛋白质,这些蛋白质的寿命通常比记忆短得多。这正是长期记忆和突触可塑性的一个基本问题:如何在不断降解的蛋白质的基础上储存人类一生的记忆?最近,研究表明,脑特异性PKC亚型,蛋白激酶M??(PKM?),在维持突触的晚期长时程增强(L-LTP)和长时程记忆中起着独特的作用。然而,这一重要的观察结果并不能解释PKM??能克服蛋白质周转和扩散的自然降解作用。这一建议的中心假设是,PKM??,通过其控制自身的合成,可以形成一个双稳态系统,从而可以占突触特异性的维持长期可塑性和记忆。在这里,我们建议在一个生物物理模型中用数学公式表示这个假设,并分析这个模型,以便提出可检验的实验预测。然后,我们将直接在PKM上测试这些预测?介导的持久性突触增强,使用新的技术专门测试的理论。智力优点:PKM??对于维持突触可塑性和长期记忆来说,这是必要的,也是足够的,这从根本上改变了学习和记忆领域,但关于实际上可以实现长期可塑性和记忆持久性的机制,还有很多需要了解。本建议使用理论和实验相结合的方法解决这些问题。这种双稳定性依赖于翻译调节的理论不仅对神经科学而且对一般生物学来说都是新颖的。我们的合作是唯一有资格进行拟议的工作,因为Shouval实验室在与实验组合作建模突触可塑性方面有丰富的经验,Sacktor实验室开创了PKM?并且对所提出的技术具有丰富的经验。实验技术包括两个新的方法,必要的测试的预测。首先,我们建议测试模型的预测蛋白质翻译L-LTP,而不是一般的蛋白质合成抑制剂,可能有毒性和间接影响的问题,但通过使用反义寡脱氧核苷酸针对翻译起始位点的PKM??mRNA特异性阻断PKM??诱导和维持中的合成。第二,因为PKM?由于L-LTP介导的增强作用既高度稳定又快速可逆,因此我们将使用为研究L-LTP的维持而优化的快速流动海马切片室来测试模型的关键预测。在计算生物学中,所提出的依赖于双稳态的随机模拟也是新颖的。更广泛的影响:作为第一个被证明的经验依赖的分子机制,长期的信息存储在大脑中,PKM??具有重要的临床意义,并且在过去的一年中已经显示出在生物学上有助于多种神经和精神疾病,包括创伤后应激障碍、中枢神经性疼痛和药物滥用。为了帮助迅速增长的兴趣PKM??在许多实验室,我们将使我们的模型可供更大的社区使用,允许其他科学家测试,修改并将他们的发现纳入模型,从而加快科学发现的步伐。因为NSF的一个重要目标是整合研究和教育,我们将培养多样化的学生。我们的实验室已经培训了本科生,Shouval实验室每年夏天都会通过一个REU项目(PI S。考克斯,赖斯),和UT系统赠款(PI H。Shouval)和当地本科生,而Sacktor实验室在指导当地弱势高中生方面有着悠久的历史(例如,通过英特尔计划)。这两个实验室都致力于公共宣传;例如,一篇关于PKM的文章?回忆登上了纽约时报的头版我们渴望将这种类型的推广扩展到生物科学理论与实验之间的相互作用领域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HAREL Zeev SHOUVAL其他文献

HAREL Zeev SHOUVAL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HAREL Zeev SHOUVAL', 18)}}的其他基金

CRCNS: PKMzeta-Dependent Protein Synthesis Maintains Synaptic Plasticity
CRCNS:PKMzeta 依赖性蛋白质合成维持突触可塑性
  • 批准号:
    8507210
  • 财政年份:
    2012
  • 资助金额:
    $ 30.75万
  • 项目类别:
CRCNS: PKMzeta-Dependent Protein Synthesis Maintains Synaptic Plasticity
CRCNS:PKMzeta 依赖性蛋白质合成维持突触可塑性
  • 批准号:
    9059060
  • 财政年份:
    2012
  • 资助金额:
    $ 30.75万
  • 项目类别:
CRCNS: PKMzeta-Dependent Protein Synthesis Maintains Synaptic Plasticity
CRCNS:PKMzeta 依赖性蛋白质合成维持突触可塑性
  • 批准号:
    8840208
  • 财政年份:
    2012
  • 资助金额:
    $ 30.75万
  • 项目类别:
CRCNS: PKMzeta-Dependent Protein Synthesis Maintains Synaptic Plasticity
CRCNS:PKMzeta 依赖性蛋白质合成维持突触可塑性
  • 批准号:
    8652969
  • 财政年份:
    2012
  • 资助金额:
    $ 30.75万
  • 项目类别:
An Integrated Approach to Synaptic Plasticity in the Hippocampus
海马突触可塑性的综合方法
  • 批准号:
    6995174
  • 财政年份:
    2005
  • 资助金额:
    $ 30.75万
  • 项目类别:
An Integrated Approach to Synaptic Plasticity in the Hippocampus
海马突触可塑性的综合方法
  • 批准号:
    7312744
  • 财政年份:
  • 资助金额:
    $ 30.75万
  • 项目类别:
An Integrated Approach to Synaptic Plasticity in the Hippocampus
海马突触可塑性的综合方法
  • 批准号:
    7463735
  • 财政年份:
  • 资助金额:
    $ 30.75万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30.75万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.75万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30.75万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.75万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30.75万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30.75万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.75万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30.75万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30.75万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.75万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了